Clinical Trials Browser

Phase 3 × Prostatic Hyperplasia × Risedronic Acid × Clear all

NCT00426777 2012-02-03

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

Phase 3 Completed

Prostatic Hyperplasia, Prostatic Neoplasms